Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Quinoline alkaloids from Cinchona may help treat cancer, diabetes, fungal infections, and promote hair growth.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

JAK inhibitors offer new hope for treating severe alopecia areata.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Tigason improved hair growth in a boy with monilethrix without side effects.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Wnt-activating drugs generally do not increase cancer risk.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.